ACORN ENERGY, INC. - Quarter Report: 2007 March (Form 10-Q)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
10-Q
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
|
SECURITIES
EXCHANGE ACT OF 1934
|
For
the quarterly period ended March
31, 2007
|
Commission
file number: 0-19771
ACORN
FACTOR, INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
22-2786081
|
|
(State
or other jurisdiction of
|
(I.R.S.
Employer
|
|
incorporation
or organization)
|
Identification
No.)
|
|
200
Route 17, Mahwah, New Jersey
|
07430
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
(201)
529-2026
(Registrant’s
telephone number, including area code)
Indicate
by check mark whether the registrant (1) has filed all reports required to
be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements
for
the past 90 days. Yes
x No
¨
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, or a non-accelerated filer. See definition of “accelerated
filer and large accelerated filer” in Rule 12b-2 of the Exchange
Act.
Large
accelerated filer ¨ Accelerated
filer ¨ Non-accelerated
filer x
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act). Yes
¨ No
x
Indicate
the number of shares outstanding of each of the issuer's classes of common
stock, as of the latest practicable date.
Class
|
Outstanding
at May 15, 2007
|
|
Common
Stock, $0.01 par value per share
|
9,586,534
shares
|
ACORN
FACTOR, INC.
Quarterly
Report on Form 10-Q
for
the Quarterly Period Ended March 31, 2007
TABLE
OF CONTENTS
PART
I. Financial Information
|
|||
Item
1.
|
Financial
Statements
|
||
Unaudited
Consolidated Financial Statements:
|
|||
Consolidated
Balance Sheets as
of December 31, 2006 and March 31, 2007
|
1
|
||
Consolidated
Statements of Operations for
the three month periods ended March 31, 2006 and
2007
|
2
|
||
Consolidated
Statement of Changes in Shareholders’ Equity for
the three month period ended March 31, 2007
|
3
|
||
|
|||
Consolidated
Statements of Cash Flows for
the three month periods ended March 31, 2006 and
2007
|
4
|
||
Notes
to Consolidated Financial Statements
|
6
|
||
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and Results of Operations
|
14
|
|
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
20
|
|
Item
4.
|
Controls
and Procedures
|
20
|
|
PART
II. Other Information
|
|||
Item
1.
|
Legal
Proceedings
|
21
|
|
Item
1A.
|
Risk
Factors
|
21
|
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
21
|
|
Item
6.
|
Exhibits
|
22
|
|
Signatures
|
23
|
Certain
statements contained in this report are forward-looking in nature. These
statements are generally identified by the inclusion of phrases such as “we
expect”, “we anticipate”, “we believe”, “we estimate” and other phrases of
similar meaning. Whether such statements ultimately prove to be accurate depends
upon a variety of factors that may affect our business and operations. Many
of
these factors are described in our most recent Annual Report on Form 10-K as
filed with Securities and Exchange Commission.
ACORN
FACTOR, INC. AND SUBSIDIARIES
Consolidated
Balance Sheets
(in
thousands, except share and per share data)
As
of December 31, 2006
|
As
of March 31, 2007
|
||||||
(unaudited)
|
|||||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
1,521
|
$
|
4,275
|
|||
Accounts
receivable, net
|
1,373
|
1,192
|
|||||
Unbilled
work-in-process
|
393
|
554
|
|||||
Other
current assets
|
316
|
512
|
|||||
Total
current assets
|
3,603
|
6,533
|
|||||
Property
and equipment, net
|
445
|
504
|
|||||
Investment
in Paketeria
|
1,212
|
1,051
|
|||||
Other
assets
|
285
|
282
|
|||||
Funds
in respect of employee termination benefits
|
1,568
|
1,541
|
|||||
Goodwill
|
97
|
96
|
|||||
Other
intangible assets, net
|
48
|
42
|
|||||
Total
assets
|
$
|
7,258
|
$
|
10,049
|
|||
LIABILITIES
AND SHAREHOLDERS’ EQUITY
|
|||||||
Current
liabilities:
|
|||||||
Short-term
bank credit
|
$
|
462
|
$
|
160
|
|||
Current
maturities of long-term debt
|
26
|
100
|
|||||
Note
payable - related party
|
300
|
300
|
|||||
Trade
accounts payable
|
378
|
378
|
|||||
Accrued
payroll, payroll taxes and social benefits
|
478
|
524
|
|||||
Other
current liabilities
|
1,700
|
1,931
|
|||||
Total
current liabilities
|
3,344
|
3,393
|
|||||
Long-term
liabilities:
|
|||||||
Investment
in Comverge, net
|
1,824
|
1,824
|
|||||
Convertible
debt, net of discounts
|
--
|
2,388
|
|||||
Liability
for employee termination benefits
|
2,545
|
2,293
|
|||||
Other
liabilities
|
6
|
4
|
|||||
Total
long-term liabilities
|
4,375
|
6,509
|
|||||
Shareholders’
equity:
|
|||||||
Common
stock - $0.01 par value per share:
|
|||||||
Authorized
- 20,000,000 shares; Issued -10,276,030 shares and 10,334,530 at
December 31, 2006 and March 31, 2007
|
102
|
103
|
|||||
Additional
paid-in capital
|
43,987
|
46,111
|
|||||
Warrants
|
888
|
1,359
|
|||||
Accumulated
deficit
|
(41,904
|
)
|
(43,906
|
)
|
|||
Treasury
stock, at cost - 777,371 shares for December 31, 2006 and March
31, 2007, respectively
|
(3,592
|
)
|
(3,592
|
)
|
|||
Accumulated
other comprehensive income
|
58
|
72
|
|||||
Total
shareholders’ equity (deficit)
|
(461
|
)
|
147
|
||||
Total
liabilities and shareholders’ equity
|
$
|
7,258
|
$
|
10,049
|
The
accompanying notes are an integral part of these consolidated financial
statements.
1
ACORN
FACTOR, INC. AND SUBSIDIARIES
Consolidated
Statements of Operations (unaudited)
(in
thousands, except per share data)
Three
months ended March 31,
|
|||||||
2006
|
2007
|
||||||
Sales
|
|||||||
Projects
|
$
|
730
|
$
|
812
|
|||
Services
|
237
|
206
|
|||||
Other
|
6
|
21
|
|||||
973
|
1,039
|
||||||
Cost
of sales
|
|||||||
Projects
|
539
|
581
|
|||||
Services
|
206
|
173
|
|||||
Other
|
—
|
—
|
|||||
745
|
754
|
||||||
Gross
profit
|
228
|
285
|
|||||
Operating
expenses:
|
|||||||
Research
and development expenses
|
26
|
130
|
|||||
Selling,
marketing, general and administrative expenses
|
922
|
810
|
|||||
Total
operating expenses
|
948
|
940
|
|||||
Operating
loss
|
(720
|
)
|
(655
|
)
|
|||
Finance
income (expense), net
|
14
|
(853
|
)
|
||||
Other
income, net
|
330
|
—
|
|||||
Loss
before taxes on income
|
(376
|
)
|
(1,508
|
)
|
|||
Taxes
on income
|
(2
|
)
|
(2
|
)
|
|||
Loss
from operations of the Company and its consolidated
subsidiaries
|
(378
|
)
|
(1,510
|
)
|
|||
Share
in losses of Comverge
|
(210
|
)
|
—
|
||||
Share
in losses of Paketeria
|
—
|
(187
|
)
|
||||
Net
loss from continuing operations
|
(588
|
)
|
(1,697
|
)
|
|||
Net
income from discontinued operations, net of tax
|
78
|
—
|
|||||
Loss
on sale of discontinued operations and contract settlement, net of
tax
|
(2,298
|
)
|
—
|
||||
Net
loss
|
$
|
(2,808
|
)
|
$
|
(1,697
|
)
|
|
Basic
and diluted income (loss) per share:
|
|||||||
Loss
per share from continuing operations
|
$
|
(0.07
|
)
|
$
|
(0.18
|
)
|
|
Discontinued
operations
|
(0.27
|
)
|
—
|
||||
Net
loss per share - basic and diluted
|
$
|
(0.34
|
)
|
$
|
(0.18
|
)
|
|
Weighted
average number of shares outstanding - basic and diluted
|
8,160
|
9,507
|
The
accompanying notes are an integral part of these consolidated financial
statements.
2
ACORN
FACTOR, INC. AND SUBSIDIARIES
Consolidated
Statement of Changes in Shareholders’ Equity (unaudited)
(in
thousands)
Number
of Shares
|
Common
Stock
|
Additional
Paid-In
Capital
|
Warrants
|
Accumulated
Deficit
|
Treasury
Stock
|
Accumulated
Other Comprehensive Income
|
Total
|
||||||||||||||||||
Balances
as of December
31, 2006
|
10,276
|
$
|
102
|
$
|
43,987
|
$
|
888
|
$
|
(41,904
|
)
|
$
|
(3,592
|
)
|
$
|
58
|
$
|
(461
|
)
|
|||||||
Net
loss
|
—
|
—
|
—
|
—
|
(1,697
|
)
|
—
|
—
|
(1,697
|
)
|
|||||||||||||||
Differences
from translation of financial statements of subsidiaries
|
—
|
—
|
—
|
—
|
—
|
—
|
14
|
14
|
|||||||||||||||||
Comprehensive
loss
|
(1,683
|
)
|
|||||||||||||||||||||||
FIN
48 adjustment
|
—
|
—
|
—
|
—
|
(305
|
)
|
—
|
—
|
(305
|
)
|
|||||||||||||||
Exercise
of options
|
59
|
1
|
113
|
—
|
—
|
—
|
—
|
114
|
|||||||||||||||||
Adjustment
of transaction costs of prior year private placement
|
—
|
—
|
68
|
—
|
—
|
—
|
—
|
68
|
|||||||||||||||||
Warrants
issued to placement agent with respect to private placement of
Debentures
|
—
|
—
|
—
|
135
|
—
|
—
|
—
|
135
|
|||||||||||||||||
Warrants
issued with respect to private placement of Debentures
|
—
|
—
|
—
|
336
|
—
|
—
|
—
|
336
|
|||||||||||||||||
Beneficial
conversion feature with respect to private placement of
Debentures
|
—
|
—
|
1,654
|
—
|
—
|
—
|
—
|
1,654
|
|||||||||||||||||
Stock
option compensation
|
—
|
—
|
289
|
—
|
—
|
—
|
—
|
289
|
|||||||||||||||||
Balances
as of March
31, 2007
|
10,335
|
$
|
103
|
$
|
46,111
|
$
|
1,359
|
$
|
(43,906
|
)
|
$
|
(3,592
|
)
|
72
|
$
|
147
|
The
accompanying notes are an integral part of these consolidated financial
statements.
3
ACORN
FACTOR, INC. AND SUBSIDIARIES
Consolidated
Statements of Cash Flows (unaudited)
(dollars
in thousands)
Three
months ended
March
31,
|
|||||||
2006
|
2007
|
||||||
Cash
flows provided by (used in) operating activities:
|
|||||||
Net
loss
|
$
|
(2,808
|
)
|
$
|
(1,697
|
)
|
|
Adjustments
to reconcile net loss to net cash provided
by (used in) operating activities:
|
|||||||
Depreciation
and amortization
|
59
|
32
|
|||||
Share
in losses of Comverge
|
210
|
—
|
|||||
Share
in losses of Paketeria
|
—
|
168
|
|||||
Decrease
in liability for employee termination benefits
|
(128
|
)
|
(252
|
)
|
|||
Amortization
of stock-based deferred compensation
|
136
|
289
|
|||||
Loss
on sale of Databit and contract settlement
|
2,298
|
—
|
|||||
Amortization
of beneficial conversion feature in private placement of
Debentures
|
—
|
827
|
|||||
Other
|
(3
|
)
|
1
|
||||
Change
in operating assets and liabilities:
|
|||||||
Decrease
(increase) in accounts receivable, unbilled work-in process and other
current and other assets
|
425
|
(172
|
)
|
||||
Increase
in inventory
|
(18
|
)
|
—
|
||||
Increase
(decrease) in accounts payable and other liabilities
|
(719
|
)
|
38
|
||||
Net
cash used in operating activities
|
(548
|
)
|
(766
|
)
|
|||
Cash
flows provided by (used in) investing activities:
|
|||||||
Release
of restricted cash
|
247
|
—
|
|||||
Release
of restricted cash (under agreement with a related party)
|
1,350
|
—
|
|||||
Investment
in Comverge
|
(210
|
)
|
—
|
||||
Amounts
funded for employee termination benefits
|
123
|
73
|
|||||
Utilization
of employee termination benefits
|
(38
|
)
|
(46
|
)
|
|||
Acquisitions
of property and equipment
|
(42
|
)
|
(76
|
)
|
|||
Sale
of Databit Inc. - Appendix A
|
(911
|
)
|
—
|
||||
Net
cash provided by (used in) investing activities
|
519
|
(49
|
)
|
||||
Cash
flows provided by (used in) financing activities:
|
|||||||
Short-term
debt repayments, net
|
(52
|
)
|
(302
|
)
|
|||
Proceeds
from long-term debt
|
—
|
107
|
|||||
Proceeds
from convertible debentures with warrants net of transaction
costs
|
—
|
3,685
|
|||||
Repayments
of long-term debt
|
(38
|
)
|
(35
|
)
|
|||
Proceeds
from employee stock option exercises
|
40
|
114
|
|||||
Net
cash provided by (used in) financing activities
|
(50
|
)
|
3,569
|
||||
Net
increase (decrease) in cash and cash equivalents
|
(79
|
)
|
2,754
|
||||
Cash
and cash equivalents at beginning of period
|
913
|
1,521
|
|||||
Cash
and cash equivalents at end of period
|
$
|
834
|
$
|
4,275
|
The
accompanying notes are an integral part of these consolidated financial
statements.
4
Non-cash
financing items
|
|||||||
Value
of beneficial conversion feature and related warrants on issuance
of
convertible debentures
|
$
|
2,125
|
|||||
Adjustment
of retained earnings and other current liabilities with respect to
the
adoption of FIN 48
|
$
|
305
|
|||||
Appendix
A
|
|||||||
Assets/liabilities
disposed of in disposition of Databit Inc. and contract
settlement:
|
|||||||
Current
assets
|
$
|
2,815
|
|||||
Non-current
assets
|
40
|
||||||
Debt
|
(20
|
)
|
|||||
Current
liabilities
|
(1,816
|
)
|
|||||
Stock
compensation costs
|
315
|
||||||
Unpaid
transaction costs in disposition of Databit and contract
settlement
|
63
|
||||||
Other
|
(10
|
)
|
|||||
Loss
on the sale of Databit and contract settlement
|
$
|
(2,298
|
)
|
||||
Net
cash used in business disposition
|
$
|
(911
|
)
|
5
ACORN
FACTOR, INC. AND SUBSIDIARIES
Notes
to Consolidated Financial Statements (unaudited)
(dollars
in thousands)
Note
1: Basis of Presentation
The
accompanying unaudited consolidated financial statements of Acorn Factor, Inc.
(“AFI”) and subsidiaries (the “Company”) have been prepared in accordance with
accounting principles generally accepted in the United States of America for
interim financial information and with the instructions to Article 10 of
Regulation S-X. Accordingly, they do not include all of the information and
footnotes required by accounting principles generally accepted in the United
States of America for complete consolidated financial statements. In the opinion
of management, all adjustments considered necessary for a fair presentation
have
been included. Operating results for the three-month period ended March 31,
2007
are not necessarily indicative of the results that may be expected for the
year
ending December 31, 2007. These unaudited consolidated financial statements
should be read in conjunction with the consolidated financial statements and
footnotes thereto included in the Company’s Annual Report on Form 10-K for the
year ended December 31, 2006. Certain
reclassifications have been made to the Company’s prior period’s consolidated
financial statements to conform to the current period’s consolidated financial
statement presentation.
Note
2: Financing of Operations
On
March
30, 2007, the Company completed the first closing of its private placement
of
10% Convertible Redeemable Subordinated Debentures (the “Debentures”) (see Note
8) raising approximately $4.3 million (approximately $3.7 million net of
commissions and expenses).
On
April
11, 2007, the Company completed the second and final closing of its private
placement of the Debentures raising an additional $2.6 million (approximately
$2.3 million net of commissions and expenses) (see Note 12(a)).
The
$3,140 of working capital at March 31, 2007, includes approximately $405 in
the
Company’s 58% owned dsIT Solutions Ltd. subsidiary (“dsIT”). Due to Israeli tax
and company law constraints, as well as dsIT’s own cash flow requirements, such
working capital and cash flows from dsIT’s operations are not readily available
to finance US based corporate activities.
dsIT
was
utilizing $160 of its approximate $400 lines of credit as of March 31, 2007.
dsIT's lines of credit are denominated in NIS and bear a weighted average
interest rate of the Israeli prime rate
plus
2.07% per
annum.
The Israeli prime rate fluctuates and as of March 31, 2007 is 5.50%.
Note
3: Accounting Change
Prior
to
January 1, 2007, the Company recognized income tax accruals with respect to
uncertain tax positions based upon Statement of Financial Accounting Standards
(SFAS) No. 5, “Accounting for Contingencies.” Under SFAS No. 5,
the Company recorded a liability associated with an uncertain tax position
if
the liability was both probable and estimable. Our liability under SFAS
No. 5 included interest and penalties, which were recognized as incurred
within “Finance income (expense), net” in the Consolidated Condensed Statements
of Operations.
Effective
January 1, 2007, the Company adopted FASB Interpretation (FIN) No. 48,
“Accounting for Uncertainty in Income Taxes.” FIN 48 clarifies the accounting
for uncertainty in income taxes recognized in financial statements in accordance
with SFAS No. 109, “Accounting for Income Taxes.” FIN 48 prescribes a
recognition threshold and measurement attribute for the financial statement
recognition and measurement of a tax position taken or expected to be taken
in a
tax return. FIN 48 requires that the Company determine whether the benefits
of
our tax positions are more likely than not of being sustained upon audit based
on the technical merits of the tax position. For tax positions that are more
likely than not of being sustained upon audit, the Company recognizes the
largest amount of the benefit that is more likely than not of being sustained
in
our consolidated financial statements. For tax positions that are not more
likely than not of being sustained upon audit, the Company does not recognize
any portion of the benefit in our consolidated financial statements. The
provisions of FIN 48 also provide guidance on de-recognition, classification,
interest and penalties, accounting in interim periods, and disclosure.
6
The
cumulative effect of the adoption of the recognition and measurement provisions
of FIN 48 resulted in a $305 reduction to the January 1, 2007 balance of
retained earnings. Results of prior periods have not been restated. The
Company’s policy for interest and penalties related to income tax exposures was
not impacted as a result of the adoption of the recognition and measurement
provisions of FIN 48. Therefore, the Company continues to recognize interest
and
penalties as incurred within “Finance income (expense), net” in the Consolidated
Statements of Operations.
The
Company is subject to U.S. federal income tax as well as state income tax and
Israeli income tax. The Company is no longer subject to examination by
U.S. Federal taxing authorities for years before 2003 and for years before
2002
for state and Israeli income taxes.
Note
4: New Accounting Standards
In
September 2006, the Financial Accounting Standards Board (“FASB”) issued
Statement of Financial Accounting Standards (“SFAS”) No. 157, “Fair Value
Measurements.” SFAS No. 157 creates a single definition of fair value,
along with a conceptual framework to measure fair value, and to increase the
consistency and the comparability in fair value measurements and in financial
statement disclosures.
In
February 2007, the FASB issued SFAS No. 159, “Fair Value Option for
Financial Assets and Liabilities - Including an Amendment to FASB Statement
No. 115.” SFAS No. 159 improves financial reporting by giving entities
the opportunity to mitigate earnings volatility by electing to measure related
financial assets and liabilities at fair value rather than using different
measurement attributes. Unrealized gains and losses on items for which the
fair
value option has been elected should be reported in earnings. Upon initial
adoption, differences between the fair value and carrying amount should be
included as a cumulative-effect adjustment to beginning retained earnings.
SFAS
Nos.
157 and 159 are effective as of the beginning of the first fiscal year that
begins after November 15, 2007. Earlier application is permitted as of the
beginning of the fiscal year that begins on or before November 15, 2007.
The Company will not early adopt SFAS Nos. 157 and 159 and is currently
assessing the impact of implementing SFAS Nos. 157 and 159 on its financial
position and results of operations.
Note
5: Investment in Comverge Inc. (Comverge)
As
the
Company’s share of losses attributable to its Comverge preferred stock has
equaled its investment in Comverge’s preferred stock, the Company ceased
recording equity losses in Comverge.
On
April
18, 2007, Comverge announced the completion of its initial public offering
of
6,095,000 shares of its common stock, at a price of $18.00 a share-see Note
12(b).
Note
6—Paketeria GmbH (Paketeria)
Paketeria’s
summary results of operations for the three-month period ended March 31, 2007
is
as follows:
Three
months ended March 31, 2007
|
||||
Sales
|
$
|
574
|
||
Gross
loss
|
$
|
(107
|
)
|
|
Net
loss
|
$
|
(403
|
)
|
7
The
Company currently owns approximately 33% of Paketeria’s outstanding shares and
accordingly, records 33% of Paketeria’s losses as equity loss in Paketeria. In
addition to the equity loss of $133, the Company recorded amortization expense
of $35 associated with acquired non-compete and franchise agreements and stock
compensation expense of $19 with respect to options granted to Paketeria’s
founder and managing director in “Share of losses in Paketeria”.
The
activity in the Company’s investments in Paketeria is as follows:
Investment
balance as of December 31, 2006
|
$
|
1,212
|
||
Amortization
of acquired non-compete and franchise agreements
|
(35
|
)
|
||
Cumulative
translation adjustment
|
7
|
|||
Company’s
share of Paketeria losses - period from January 1, 2007 to March
31,
2007
|
(133
|
)
|
||
Investment
balance as of March 31, 2007
|
$
|
1,051
|
In
January 2007, the Company lent Paketeria €75 ($99, based upon the then current
exchange rate) for a period of three months on a note payable. The note bears
interest at the rate of 8.0%. The note is immediately due and payable to the
extent net proceeds are raised by Paketeria through any equity and/or debt
financing. In March 2007, the Company lent Paketeria an additional €75 ($101,
based upon the then current exchange rate) for a period of three months on
a
note payable under similar terms as the previous note except that the note
bears
interest at the rate of 10.0%. The Note receivable balances are included in
Other Current Assets in the Consolidated Balance Sheets.
Note
7: Goodwill and Other Intangible Assets
There
were no acquisitions or impairments of goodwill recorded during the three-month
period ended March 31, 2007. All the goodwill is related to the OncoPro™ segment
in dsIT.
The
Company’s amortizable intangible assets consisted of software licenses, with a
gross carrying amount of $224 and accumulated amortization of $176 and $182,
as
of December 31, 2006 and March 31, 2007, respectively. All intangibles assets
are being amortized over their estimated useful lives, which averaged five
years
and the amortization
expense for each of the three months ended March 31, 2006 and 2007 amounted
to
$10 and $6, respectively. Amortization expense of the remaining balance of
these
assets, for the years ending March 31, 2008, 2009 and 2010, is estimated to
be
$21 $8, $8 and $5, respectively.
Note
8: Private Placement of Convertible Redeemable Subordinated Debentures
On
March
30, 2007, the Company conducted an initial closing of a private placement of
its
Debentures. At the initial closing the Company issued $4,281 principal amount
of
the Debentures, at par, and received gross proceeds in the same amount.
8
From
the
date of issuance of the Debentures to and including, the first anniversary
of
the initial closing, 50% of the outstanding principal amount of the Debentures
is convertible into shares of the Company’s Common Stock at a price of $3.80 per
share. Following the first anniversary of the initial closing, the Debentures
are convertible up to the entire principal amount then outstanding. In
connection with the convertible feature embedded in the Debentures, the Company
has determined the beneficial conversion feature to be $1,654. In according
with
applicable accounting principles, one-half ($827) was immediately charged to
finance expense, net, due to the ability to convert one-half of the Debentures
at issuance. The remaining balance of the beneficial conversion feature ($827)
is reflected as a discount to the total Debenture amount and will be charged
to
interest expense over a one-year period (the period after which the remaining
one-half of the Debentures may be converted).
By
the
terms of the offering, each subscriber, in addition to the Debentures, received
a warrant exercisable for the purchase of a number of shares equal to 25% of
the
principal amount of the Debentures purchased by such subscriber, divided by
the
conversion price of $3.80, resulting in the issuance at the initial closing
of
Warrants to purchase 281,656 shares. The Warrants are exercisable for
shares of the Company’s Common Stock for five years at an exercise price of
$4.50 per share and are callable by the Company at any time after the
effectiveness of the registration statement and provided that the registration
statement has been effective during the period of notice and is effective at
the
time of the call, the Warrants are subject to call for cancellation, at the
option of the Company, on 20 business days notice, upon the Common Stock having
achieved a volume weighted average price of $6.00 or more for 20 consecutive
trading days. The Company allocated $336 to the value of the warrants based
on a
valuation performed by an independent consultant who utilized the Call Cap
Option Pricing Model reflecting the callable feature embedded in the
warrant. The value allocated to the warrants has been reflected as a discount
to
the total Debenture amount and will be charged to interest expense over the
five-year life of the warrants.
The
Debentures bear interest at the rate of 10% per annum, payable quarterly and
mature on March 30, 2011. If the Company fails to redeem at least 50% of the
total outstanding principal amount of the Debentures, together with interest
accrued thereon, by the first anniversary of the initial closing, the annual
rate of interest payable on the Debentures will be increased to
12%.
In
connection with the offering, the Company retained a registered broker-dealer
to
serve as placement agent. In accordance with the terms of the agreement, the
placement agent received a 7% selling commission, 3% management fee, and 2%
non-accountable expense allowance, out of the gross proceeds of the offering.
In
addition, the placement agent was entitled to and received warrants on
substantially the same terms as those issued to the subscribers, exercisable
for
the purchase of the number of shares equal to 10% of the total principal amount
of the Debentures sold, divided by the conversion price of $3.80. Out of the
gross proceeds received at the initial closing, the Company paid the placement
agent commissions and expenses of $596 and issued to the placement agent
warrants to purchase 112,658 shares of Common Stock. The value of the warrants
issued to the placement agent was determined to be $134 based upon the valuation
performed by the independent consultant mentioned above. In addition, the
Company paid various other transaction costs of $596. The total debt origination
costs of $730 has been reflected as a discount against the total Debenture
amount and are to be charged to interest expense over the four year life of
the
Debentures.
On
April
11, 2007, the Company conducted a second and final closing and completed its
$6.9 million private placement of the Debentures (see Note 12(a)).
9
Note
9: Stock Options and Warrants
(a)
Acorn
Stock Options
A
summary
of stock option activity for the three months ended March 31, 2007 is as
follows:
Number
of Options (in shares)
|
Weighted
Average Exercise Price
|
Weighted
Average Remaining Contractual Life
|
Aggregate
Intrinsic Value
|
||||||||||
Outstanding
at December 31, 2006
|
2,172,835
|
$
|
2.55
|
||||||||||
Granted
at market price
|
66,000
|
$
|
4.53
|
||||||||||
Granted
at discount to market price
|
79,000
|
$
|
3.50
|
||||||||||
Exercised
|
(58,500
|
)
|
$
|
1.95
|
$
|
131
|
|||||||
Forfeited
or expired
|
(79,000
|
)
|
$
|
3.50
|
|||||||||
Outstanding
at March 31, 2007
|
2,180,335
|
$
|
2.63
|
3.1
years
|
$
|
5,261
|
|||||||
Exercisable
at March 31, 2007
|
1,638,658
|
$
|
2.54
|
2.4
years
|
$
|
4,132
|
The
weighted average grant date fair value of 145,000 stock options granted during
the first three months of 2007 was $1.14 per share. The fair value of the
options granted was estimated on the grant date using the Black-Scholes
option-pricing model with the following weighted average
assumptions:
Volatility
|
50%
|
Expected
term (years)
|
1.0
years
|
Risk
free interest rate
|
5.0%
|
Expected
dividend yield
|
0.0%
|
Total
stock-based compensation expense included in the Company’s statements of
operations for the three months ended March 31, 2006 and 2007, respectively,
was:
Three
months ended March 31, 2006
|
Three
months ended March 31, 2007
|
||||||
Cost
of sales
|
$
|
19
|
$
|
21
|
|||
Selling,
marketing, general and administrative expenses
|
116
|
249
|
|||||
Share
of losses in Paketeria
|
—
|
19
|
|||||
Loss
on sale of discontinued operations and contract settlement
|
315
|
—
|
|||||
Total
stock based compensation expense
|
$
|
450
|
$
|
289
|
10
(b)
dsIT
Stock Option Plan
In
February 2007, certain members of senior management and employees of dsIT
exercised options under the dsIT Key Employee Stock Option Plan. As a result
of
the exercise of these options, the Company’s holdings in dsIT were diluted to
58%.
(c)
Warrants
As
noted
above in Note 8, the Company issued warrants in connection with its private
placement of the Debentures.
A
summary
of stock warrants activity for the three months ended March 31, 2007 is as
follows:
Number
of Warrants (in shares)
|
Weighted
Average Exercise Price
|
Weighted
Average Remaining Contractual Life
|
||||||||
Outstanding
at December 31, 2006
|
614,039
|
$
|
2.79
|
3.2
years
|
||||||
Granted
|
394,314
|
$
|
4.50
|
5.0
years
|
||||||
Exercised
|
—
|
—
|
||||||||
Forfeited
or expired
|
—
|
—
|
||||||||
Outstanding
at March 31, 2007
|
1,008,353
|
$
|
3.46
|
3.9
years
|
||||||
Exercisable
at March 31, 2007
|
1,008,353
|
$
|
3.46
|
3.9
years
|
Note
10: Warranty Provision
The
Company generally grants its customers one-year product warranty. No provision
was made in respect of warranties based on the Company’s previous
history.
Note
11: Segment Information
The
Company has redefined its reported operating segments. The Company no longer
considers its Easybill operations as part of its former IT Solutions segment
(current consisting only of OncoPro™ activities) as the Company has reduced its
focus on those activities. Easybill activities are currently included in
“Other”. The Company’s current operations are based upon the following two
operating segments:
· |
RT
Solutions whose activities are focused on two areas - naval solutions
and
other real-time and embedded hardware & software
development.
|
· |
OncoPro™
whose activities are comprised of the Company’s OncoPro™ solution state of
the art chemotherapy package for oncology and hematology
departments.
|
Other
operations include various operations in Israel that do not meet the
quantitative thresholds of SFAS No. 131.
11
Prior
year segment disclosures have been conformed to the new segment presentation.
RT
Solutions
|
OncoPro™
|
Other
(*)
|
Total
|
||||||||||
Three
months ended March 31, 2007:
|
|||||||||||||
Revenues
from external customers
|
$
|
679
|
$
|
172
|
$
|
188
|
$
|
1,039
|
|||||
Intersegment
revenues
|
—
|
—
|
—
|
—
|
|||||||||
Segment
gross profit
|
175
|
96
|
14
|
285
|
|||||||||
Segment
income (loss)
|
36
|
(62
|
)
|
—
|
(26
|
)
|
|||||||
Three
months ended March 31, 2006:
|
|||||||||||||
Revenues
from external customers
|
$
|
555
|
$
|
171
|
$
|
247
|
$
|
973
|
|||||
Intersegment
revenues
|
—
|
—
|
—
|
—
|
|||||||||
Segment
gross profit
|
160
|
42
|
26
|
228
|
|||||||||
Segment
income (loss)
|
(49
|
)
|
(37
|
)
|
(31
|
)
|
(117
|
)
|
(*) Represents
various operations in Israel that did not meet the quantitative thresholds
of
SFAS No. 131.
Reconciliation
of Segment Income (Loss) to Consolidated Net Loss
Three
months ended March 31,
|
|||||||
2006
|
2007
|
||||||
Total
loss for reportable segments
|
$
|
(86
|
)
|
$
|
(26
|
)
|
|
Other
operational segment income (loss)
|
(31
|
)
|
—
|
||||
Total
operating income (loss)
|
(117
|
)
|
(26
|
)
|
|||
Share
of losses in Paketeria
|
—
|
(187
|
)
|
||||
Share
of losses in Comverge
|
(210
|
)
|
—
|
||||
Net
loss of corporate headquarters and other unallocated costs
|
(261
|
)
|
(1,484)*
|
||||
Net
loss from continuing operations
|
(588
|
)
|
(1,697
|
)
|
|||
Discontinued
operations
|
78
|
—
|
|||||
Loss
on sale of discontinued operations and contract settlement
|
(2,298
|
)
|
—
|
||||
Total
consolidated net loss
|
$
|
(2,808
|
)
|
$
|
(1,697
|
)
|
*
Includes $827 of interest expense with respect to the beneficial conversion
feature in the private placement of Debentures (see Note 8).
Note
12: Subsequent Events
(a)
Private Placement of Convertible Redeemable Subordinated Debentures
On
April
11, 2007, the Company completed the second and final closing of the private
placement of its Debentures described in Note 8. At the final closing the
Company issued $2,605 principal amount of the Debentures, at par, and received
gross proceeds in the same amount. The Debentures issued at the final closing
have the same terms as those issued at the initial closing described in Note
8.
In addition to the Debentures, at the final closing subscribers received a
warrant exercisable for the purchase of a number of shares equal to 25% of
the
principal amount of the Debentures purchased divided by the conversion price
of
$3.80, resulting in the issuance at the final closing of Warrants to purchase
171,391 shares. The Warrants are exercisable for shares of the Company’s Common
Stock for five years at an exercise price of $4.50 per share and are callable
by
the Company in certain circumstances. Warrants to issue a total of 453,047
shares of Common Stock were issued to subscribers in the first and second
closings.
12
Out
of
the gross proceeds received at the final closing, the Company paid to the
placement agent for the offering commissions and expenses of approximately
$325.
In addition, in connection with the final closing, the Company issued to the
placement agent warrants to purchase an additional 68,553 shares of Common
Stock
on the same terms as those issued to the subscribers. The total of placement
agent commissions and expenses paid in connection with the offering was $864
and
the total number of warrants issued to the placement agent was
181,211.
(b)
Comverge IPO
On
April
18, 2007, Comverge announced the completion of its initial public offering
of
6,095,000 shares of common stock, including 795,000 shares sold pursuant to
the
exercise by the underwriters of their over-allotment option granted to them
by
certain selling stockholders. The shares are listed on the Nasdaq Global Market
under the symbol "COMV". The Company did not sell any of its shares of Comverge
common stock in the offering.
Immediately
prior to the closing of the Comverge offering on April 18, 2007, all shares
of
preferred stock of Comverge were converted to common stock of Comverge and
the
Company currently owns 2,786,021 shares of Comverge common stock, representing
15.9% of the issued and outstanding capital stock of Comverge following the
offering.
In
connection with the offering, the Company (and all of Comverge’s executive
officers, directors and certain of other major stockholders of Comverge),
entered into a lock-up agreement under which the Company agreed, subject to
limited exceptions, not to transfer or otherwise dispose of any shares of
Comverge common stock for a period of at least 180 days from the date of
effectiveness of the offering without the prior written consent of the lead
manager of the offering.
When
an
equity method investee such as Comverge issues additional shares to third
parties, the percentage ownership interest in the investee decreases. In the
event the issuance price per share is higher or lower than the Company’s average
carrying amount per share, the Company recognizes a non-cash gain or loss on
the
issuance. This non-cash gain or loss, net of any deferred taxes, is recognized
in the Company’s net income in the period the change of ownership interest
occurs. As a result of the Comverge IPO, the Company expects to record a
non-cash gain of approximately $15.5 million. Subsequent to the offering, the
Company will no longer be accounting for its investment in Comverge under the
equity method and will account for its Comverge investment under the cost
method.
13
ACORN
FACTOR, INC.
Management’s
Discussion and Analysis of
Financial
Condition and Results of Operations
Item
2. Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
The
following discussion includes statements that are forward-looking in nature.
Whether such statements ultimately prove to be accurate depends upon a variety
of factors that may affect our business and operations. Certain of these factors
are discussed in this report and in our Annual Report on Form 10-K for the
year
ended December 31, 2006.
Recent
Developments
Private
Placement of Debentures and Warrants
On
April
11, 2007, we completed a private placement of $6.9 million of principal amount
of 10% Convertible Redeemable Subordinated Debentures (the “Debentures”),
resulting in gross proceeds of the same amount. The Debentures, subject to
certain restrictions, are convertible into our common stock at a conversion
price of $3.80 per share and mature on March 30, 2011.
In
connection with the offering, we entered into subscription agreements with
certain accredited investors. By the terms of the subscription agreements each
subscriber in addition to the Debentures purchased, received a warrant
exercisable for the purchase of 25% of the number of shares obtained by dividing
the principal amount of a given Debenture by the conversion price of $3.80
per
share, resulting in the issuance of warrants to purchase 453,047 shares. The
warrants are exercisable for shares of Common Stock for a period of five years
at an exercise price of $4.50 per share. Both the Debentures and the warrants
are redeemable by us in certain circumstances.
In
connection with the offering, we retained a registered broker-dealer to serve
as
placement agent. In accordance with the terms of our agreement with the
placement agent, the agent received a 7% selling commission, 3% management
fee,
and 2% non-accountable expense allowance out of the gross proceeds of the
offering.
Out
of
the gross proceeds of the offering, we paid the placement agent commissions
and
expenses of approximately $0.9 million. In addition, we issued to the placement
agent warrants to purchase 181,211 shares of common stock on substantially
the
same terms as those issued to the subscribers.
Comverge
IPO
On
April
18, 2007, Comverge announced the completion of its initial public offering
of
6,095,000 shares of common stock, including 795,000 shares sold pursuant to
the
exercise by the underwriters of the over-allotment option granted to them by
certain selling stockholders. The shares are listed on the Nasdaq Global Market
under the symbol "COMV". We did not sell any of our Comverge common stock in
the
offering.
Immediately
prior to the closing of the Comverge offering on April 18, 2007, all shares
of
preferred stock of Comverge were converted to common stock of Comverge and
we
currently own 2,786,021 shares of Comverge common stock, representing 15.9%
of
the issued and outstanding capital stock of Comverge following the
offering.
In
connection with the offering, we (and all of Comverge’s executive officers,
directors and certain of other major stockholders of Comverge), entered into
a
lock-up agreement under which the we agreed, subject to limited exceptions,
not
to transfer or otherwise dispose of any shares of Comverge common stock for
a
period of at least 180 days from the date of effectiveness of the offering
without the prior written consent of the lead manager of the
offering.
14
Paketeria
In
April
2007, we provided Paketeria with an additional short-term loan (three-months)
of
am amount in euros equal to approximately $165,000 in order to provide it with
additional short-term financing to help it support its current expansion and
operating activities until it raises funds from a debt or equity
offering.
Overview
and Trend Information
During
the periods included in this report, we operated in two reportable segments:
RT
Solutions and OncoPro™. The following analysis should be read together with the
segment information provided in Note 11 to the interim unaudited consolidated
financial statements included in this quarterly report, which information is
hereby incorporated by reference into this Item 2.
RT
Solutions
Segment
revenues reflected a marginal decrease in the first quarter of 2007 as compared
to the fourth quarter of 2006, but showed a significant increase over first
quarter 2006 revenues. Segment gross profits decreased slightly reflecting
the
marginal decrease in sales and were also due to reduced profit margins. We
are
continuing our discussions for strategic alliances for marketing our sonar
solutions. We believe that sonar technology solutions will be the primary source
of this segment’s future growth and profitability. We expect that we will begin
to see increased revenues from our sonar technologies solutions in the coming
quarters.
OncoPro™
Segment
revenues and gross profit margins decreased significantly in the first quarter
of 2007 as compared to the fourth quarter of 2006. We continue to invest
significant resources to adapt our OncoPro™ solutions
software to the US market. We are also continuing our discussions for a
beta-site in the US and strategic alliances for marketing and obtaining
additional investment for our OncoPro™ solutions.
Segment
revenues decreased somewhat in the first quarter of 2007 as compared to the
fourth quarter of 2006, but were stable as compared to the first quarter of
2006. Segment gross profit and gross margins both decreased in the first quarter
of 2007 as compared to the fourth quarter of 2007, but increased compared to
the
first quarter of 2006.
We
hope
to successfully complete our beta-site work in the second half of 2007 and
begin
sales of OncoPro™ in the United States in the second half of 2007. . We also
anticipate higher development costs associated with the beta-site work and
do
not expect this segment to reach profitability before 2008.
Comverge
As
described above under “Recent Developments”, on April 18, 2007 Comverge
announced the completion of its initial public offering. Comverge plans to
use
the net proceeds from the offering to finance current and future capital
requirements of its VPC™ contracts, to finance research and development, to
repay indebtedness, to fund any cash consideration for future acquisitions
and
for other general corporate purposes.
15
Paketeria
We
account for our Paketeria investment the equity method and, as such, currently
record approximately 33% of its income or loss in our consolidated
results.
Paketeria
was established to take advantage of the privatization and subsequent
substantial reduction in retail outlets of the German post office. Since the
beginning of 2006, Paketeria has doubled in size to four company owned stores
and 60 franchised stores. In 2007, Paketeria is planning to continue its
expansion of stores. In addition, Paketeria is planning to add additional
services to its unique “Super Services Market” format. Planned additions to its
services menu include an Internet pharmacy and telecommunication services in
cooperation with The Phone House, Europe’s largest independent mobile phone
retailer. In addition, Paketeria will be seeking additional capital investment
to help fund its activities and expansion.
In
2007,
we have lent Paketeria approximately $365,000 to help it finance its ongoing
activities and expansion. Paketeria is currently looking for additional outside
equity or debt financing to assist it in its expansion.
Corporate
We
have
recently raised approximately $6.9 million in a private placement of our
Convertible
Redeemable Subordinated Debentures. We intend to use the funds raised for
general working capital and to finance our search for additional strategic
acquisitions and investments.
New
Accounting Standards
Effective
January 1, 2007, we adopted FASB Interpretation No. (FIN) 48,
“Accounting for Uncertainty in Income Taxes.” FIN 48 clarifies the accounting
for uncertainty in income taxes recognized in financial statements in accordance
with SFAS No. 109, “Accounting for Income Taxes.” FIN 48 prescribes a
recognition threshold and measurement attribute for the financial statement
recognition and measurement of a tax position taken or expected to be taken
in a
tax return. FIN 48 requires that we determine whether the benefits of our tax
positions are more likely than not of being sustained upon audit based on the
technical merits of the tax position. For tax positions that are more likely
than not of being sustained upon audit, we recognize the largest amount of
the
benefit that is more likely than not of being sustained in our consolidated
financial statements. For tax positions that are not more likely than not of
being sustained upon audit, we do not recognize any portion of the benefit
in
our consolidated financial statements. The provisions of FIN 48 also provide
guidance on de-recognition, classification, interest and penalties, accounting
in interim periods, and disclosure.
The
cumulative effect of the adoption of the recognition and measurement provisions
of FIN 48 resulted in a $305,000 reduction to the January 1, 2007 balance
of our retained earnings. Results of prior periods have not been restated.
Our
policy for interest and penalties related to income tax exposures was not
impacted as a result of the adoption of the recognition and measurement
provisions of FIN 48. Therefore, we continue to recognize interest and penalties
as incurred within “Finance income (expense), net” in the Consolidated
Statements of Operations.
16
Results
of Operations
The
following table sets forth certain information with respect to the consolidated
results of operations of the Company for the three months ended March 31, 2006
and 2007, including the percentage of total revenues during each period
attributable to selected components of the operations statement data and for
the
period to period percentage changes in such components.
Three
months ended March 31,
|
Change
from
2006
to
|
|||||||||||||||
2006
|
2007
|
2007
|
||||||||||||||
($,000)
|
%
of sales
|
($,000)
|
%
of sales
|
%
|
||||||||||||
Sales
|
$
|
973
|
100
|
%
|
1,039
|
100
|
%
|
7
|
||||||||
Cost
of sales
|
745
|
77
|
754
|
73
|
1
|
|||||||||||
Gross
profit
|
228
|
23
|
285
|
27
|
25
|
|||||||||||
R&D
expenses
|
26
|
3
|
130
|
13
|
400
|
|||||||||||
SMG&A
expenses
|
922
|
95
|
810
|
78
|
(12
|
)
|
||||||||||
Operating
loss
|
(720
|
)
|
(74
|
)
|
(655
|
)
|
(63
|
)
|
(9
|
)
|
||||||
Finance
income (expense), net
|
14
|
(1
|
)
|
(853
|
)
|
(82
|
)
|
(6,193
|
)
|
|||||||
Other
income , net
|
330
|
34
|
--
|
(100
|
)
|
|||||||||||
Loss
before taxes on income
|
(376
|
)
|
(39
|
)
|
(1,508
|
)
|
(145
|
)
|
301
|
|||||||
Taxes
on income
|
2
|
0
|
2
|
0
|
0
|
|||||||||||
Loss
from operations of the Company and its consolidated
subsidiaries
|
(378
|
)
|
(39
|
)
|
(1,510
|
)
|
(145
|
)
|
299
|
|||||||
Share
in losses of Comverge
|
(210
|
)
|
(22
|
)
|
--
|
(100
|
)
|
|||||||||
Share
in losses of Paketeria
|
--
|
--
|
(187
|
)
|
(18
|
)
|
||||||||||
Net
loss from continuing operations
|
(588
|
)
|
(60
|
)
|
(1,697
|
)
|
(163
|
)
|
189
|
|||||||
Net
income from discontinued operations, net of tax
|
78
|
8
|
--
|
(100
|
)
|
|||||||||||
Loss
on sale of discontinued operations and contract settlement
|
(2,298
|
)
|
(236
|
)
|
--
|
(100
|
)
|
|||||||||
Net
loss
|
$
|
(2,808
|
)
|
(289
|
)
|
$
|
(1,697
|
)
|
(163
|
)
|
(40
|
)
|
Sales.
Sales in
the first three months of 2007 increased by $66,000 or 7% from $973,000 in
the
first quarter of 2006 to $1,039,000 in the first quarter of 2007. The increase
was primarily attributable to an increase in RT Solutions segment sales
partially offset by a decrease in other non-segment sales.
Gross
profit. Gross
profits in the first three months of 2007 increased by $57,000 or 25% as
compared to the first quarter of 2006. The increase was due to increases in
both
gross profit in both of our RT Solutions and our OncoProTM
operating segments. The increase in RT Solutions gross profit was due to
increased sales whereas the increase in OncoProTM
gross
profit was due to an increase in the gross margin.
Selling,
marketing, general and administrative expenses (“SMG&A”). SMG&A
in the first three months
of
2007 decreased by $112,000 or 12% as compared to the first three months of
2006.
This decrease was due primarily to a waiver of certain liabilities by senior
management in our dsIT subsidiary in order to shore up its results and maintain
its working relationship with its banks. This reduction was partially offset
by
a $133,000 increase in stock option compensation expense recorded with respect
to SFAS 123R.
Finance
income (expense), net. The
increase in finance expense in the first three months of 2007 compared with
the
first three months of 2006 is due primarily to the interest expense of $827,000
recorded with respect to the beneficial conversion feature associated with
the
recent private placement of our Debentures.
17
Other
income (expense), net. In
the
first quarter of 2006, we
reached
a settlement agreement with an Israeli bank with respect to our claims against
the bank and the bank’s counterclaim against us. As a result of the settlement
agreement, we recorded income of $330,000, net of legal expenses.
Share
of losses in Comverge. In
the
first quarter of 2006, we recognized $210,000 in previously unrecognized and
current losses of our Comverge equity affiliate offsetting our additional
investments during the quarter in that amount in Comverge preferred stock.
As
our investment in Comverge has been reduced to zero, we no longer recorded
additional losses against our investment in Comverge.
Share
of losses in Paketeria. In
the
first quarter of 2007, we recognized $133,000 representing our approximately
33%
share of Paketeria’s losses for the period. In addition, we also recognized
additional losses totaling $54,000 with respect to stock compensation expense
associated with a previous option grant to Paketeria’s founder and managing
director and amortization related to the acquired value of a non-compete
agreement and franchises.
Net
income from discontinued operations, net of tax. The
results as reported reflect the net results of Databit prior to our sale in
March of 2006.
Loss
on sale of discontinued operations and contract settlement, net of tax.
This
loss
resulted from the sale of our Databit computer hardware company and contract
settlement with our former CEO during the first quarter of 2006.
Liquidity
and Capital Resources
As
of
March 31, 2007, we had working capital of $3.1 million, including $4.3 million
of cash and cash equivalents. Net cash provided in the first quarter of 2007
was
$2.8 million. Net cash of $0.8 million was used in operating activities during
the first quarter of 2007. The primary use of cash in operating activities
during the first quarter of 2007 was our corporate expenses of $0.6 million
and
the net increase in our accounts receivables of $0.2 million. Net cash of $3.6
million was provided from financing activities, primarily from the proceeds
of
our private placement of debentures and warrants net of related discounts ($3.7
million, net).
Of
our
total working capital, on March 31, 2007, $0.4 million was in our majority
owned
dsIT subsidiary. Due to Israeli tax and company law constraints as well as
dsIT’s own working capital requirements, such working capital and cash flows
from dsIT’s operations are not readily available to finance U.S. corporate
activities.
As
of
April 30, 2007 the Company’s wholly owned US operations (i.e., excluding dsIT)
had an aggregate of approximately $6.0 million in cash and cash equivalents,
reflecting a $4.5 million increase from the balance as of December 31, 2006.
We
believe that the cash available will provide more than sufficient liquidity
to
finance Acorn’s activities for the foreseeable future and for the next 12 months
in particular. As of March 31, 2007, dsIT was utilizing approximately $160,000
of its approximate $400,000 lines of credit. dsIT's lines of credit are
denominated in NIS and bear a weighted average interest rate of the Israeli
prime rate plus 2.07% per annum. The Israeli prime rate fluctuates and as of
March 31, 2007 was approximately 5.5%. In February 2007, dsIT and one of its
banks agreed to convert NIS 450,000 (or approximately $107,000) of its lines
of
credit to a term loan to be paid over a period of one-year with the terms of
the
remaining balance in the line of credit to be revisited in June 2007. At March
31, 2007, dsIT was in technical violation of covenants under its line of credit
with its other bank. This bank is continuing to provide funding to dsIT despite
the technical violation and has not formally notified dsIT of any violation
or
any contemplated action. Acorn has agreed to be supportive of dsIT’s liquidity
requirements over the next 12 months.
18
Contractual
Obligations and Commitments
Our
contractual obligations and commitments at March 31, 2007, excluding certain
severance arrangements described below, principally include obligations
associated with our outstanding indebtedness, future minimum operating lease
obligations and potential severance obligations to Israeli employees and are
set
forth in the table below.
Cash
Payments Due During Year Ending March 31,
|
||||||||||||||||
(amounts
in thousands)
|
||||||||||||||||
Contractual
Obligations
|
Total
|
2008
|
2009-2010
|
2011-2012
|
2013
and thereafter
|
|||||||||||
Long-term
debt
|
$
|
4,381
|
$
|
100
|
$
|
—
|
$
|
4,281*
|
$
|
—
|
||||||
Operating
leases (1)
|
1,055
|
561
|
494
|
—
|
—
|
|||||||||||
Potential
severance obligations to Israeli employees (2)
|
2,293
|
—
|
—
|
—
|
2,293
|
|||||||||||
Investor
relations
|
—
|
46
|
—
|
—
|
—
|
|||||||||||
Buy-out
of Paketeria loan (3)
|
93
|
93
|
—
|
—
|
—
|
|||||||||||
Total
contractual cash obligations
|
$
|
7,868
|
$
|
800
|
$
|
494
|
$
|
4,281
|
$
|
2,293
|
*
The
long-term debt due in the period 2011-2012 does not include the $2.6 million
due
as a result of the completion of the private placement of our Debentures in
April 2007 (see Overview and Trend Information).
We
expect
to finance these contractual commitments from cash on hand and cash generated
from operations.
(1)
As
part of the sale of our Databit computer hardware subsidiary, we assigned all
of
the US leases to Databit and after the first quarter of 2006 will no longer
have
rental expense for facilities in the US. However, the landlords of the
properties have not yet consented to the assignments and we therefore continue
to be contingently liable on these leases, which have an annual cost of
approximately $120,000 until November 2008. Such costs are included in the
table
above. Databit has agreed to indemnify us for any liability in connection with
these leases. Under the terms of the sale agreement with Databit, we continue
to
house certain corporate headquarter functions in Mahwah, New Jersey. Under
a
transition services arrangement, we have agreed to pay Databit $20,000 per
year
for the continued use of the Mahwah premises and various administrative
services.
(2)
Under
Israeli law and labor agreements, dsIT is required to make severance payments
to
dismissed employees and to employees leaving employment under certain other
circumstances. The obligation for severance pay benefits, as determined by
the
Israeli Severance Pay Law, is based upon length of service and ending salary.
These obligations are substantially covered by regular deposits with recognized
severance pay and pension funds and by the purchase of insurance policies.
As of
March 31, 2007, we accrued a total of $2.3 million for potential severance
obligations of which approximately $1.5 million was funded with cash to
insurance companies.
(3)
As a
part of our initial agreement to invest in Paketeria, we agreed to the purchase
of a €210,000 ($280,000) principal promissory note issued by Paketeria to
its founder and managing director. Under the terms of the agreement, we must
purchase one-third of the note from the founder for a cash payment equal to
one-third of the principal amount, plus accrued interest, upon Paketeria having
achieved each of three franchise licensing milestones—the licensing of its 60th,
75th, and 115th franchises. In 2006, we purchased the first two-thirds of the
€210,000 ($280,000) principal promissory note. We expect to purchase the
remaining €70,000 ($93,000) of the note within the next year, upon the
achievement of the third and final milestone.
19
Item
3.
Quantitative and Qualitative Disclosures About Market Risk
In
the
normal course of business, we are exposed to fluctuations in interest rates
on
lines-of-credit incurred to finance our operations in Israel, currently
approximately $160,000. Additionally, our monetary assets and liabilities (net
liability of approximately $0.3 million) in Israel are exposed to fluctuations
in exchange rates. We do not employ specific strategies, such as the use of
derivative instruments or hedging, to manage our interest rate or foreign
currency exchange rate exposures.
Item
4.
Controls and Procedures
Evaluation
of Controls and Procedures
As
of the
end of the period covered by this report, we carried out an evaluation, under
the supervision and with the participation of our management, including the
Chief Executive Officer and the Chief Financial Officer, of the design and
operation of our disclosure controls and procedures (as such term is defined
in
Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the
“Exchange Act’)). Based on this evaluation, our Chief Executive Officer and
Chief Financial Officer concluded that our disclosure controls and procedures
were effective at the reasonable assurance level at end of the period covered
by
this report to ensure that the information required to be disclosed by us in
the
reports we file or submit under the Exchange Act is (i) accumulated and
communicated to our management (including our Chief Executive Officer and Chief
Financial Officer) in a timely manner, and (ii) recorded, processed, summarized
and reported within the time periods specified in the SEC’s rules and
forms.
Changes
in Controls and Procedures
There
was
no change in our internal controls over financial reporting (as such term is
defined in Rule 13a-15(f) under the Exchange Act) during the period covered
by
this report that has materially affected, or is reasonably likely to materially
affect, internal controls over financial reporting.
20
PART
II - OTHER INFORMATION
Item
1. Legal
Proceedings
None.
Item
1A. Risk Factors
In
addition to the other information set forth in this report, you should carefully
consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual
Report on Form 10-K for the year ended December 31, 2006, which could materially
affect our business, financial condition or future results. The risks described
in our Annual Report on Form 10-K are not the only risks facing our company.
Additional risks and uncertainties not currently known to us or that we
currently deem to be immaterial also may materially adversely affect our
business, financial condition and/or operating results.
Item
2. Unregistered Sales of Equity Securities and Use of
Proceeds
None.
21
Item
6. Exhibits.
4.1
|
Form
of Convertible Debenture (incorporated herein by reference to Exhibit
4.9
to the Registrant’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2006, (the “2006 10-K”).
|
|
4.2
|
Form
of Warrant (incorporated herein by reference to Exhibit 4.10 to the
2006
10-K).
|
|
#4.3
|
Form
of Agent Warrant.
|
|
10.1
|
Acorn
Factor, Inc. 2006 Stock Option Plan for Non-Employee Directors
(incorporated herein by reference to Exhibit 10.1 to the Registrant’s
Current Report on Form 8-K dated February 8, 2007 (the “February 2007
8-K”).*
|
|
10.2
|
Acorn
Factor, Inc. 2006 Stock Incentive Plan (incorporated herein by reference
to Exhibit 10.2 to the February 2007 8-K).*
|
|
10.3
|
Form
of Subscription Agreement (incorporated herein by reference to Exhibit
10.47 to the 2006 10-K).
|
|
10.4
|
Placement
Agent Agreement between First Montauk Securities Corp. and the Registrant
dated March 8, 2007(incorporated herein by reference to Exhibit 10.48
to
the 2006 10-K) .
|
|
#31.1
|
Certification
of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|
#31.2
|
Certification
of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|
#32.1
|
Certification
of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.
|
|
#32.2
|
Certification
of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.
|
#
This Exhibit is filed herewith.
22
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by its Principal Financial
Officer thereunto duly authorized.
ACORN
FACTOR, INC.
|
||
|
|
|
Dated:
May 16, 2007
|
By: |
/s/
Michael
Barth
|
Michael
Barth
|
||
Chief
Financial Officer
|
23